Kronos Worldwide (KRO)
(Delayed Data from NYSE)
$11.86 USD
-0.11 (-0.92%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $11.84 -0.02 (-0.17%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.86 USD
-0.11 (-0.92%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $11.84 -0.02 (-0.17%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Zacks News
Kronos Worldwide (KRO) Misses on Q2 Earnings, Sales Up Y/Y
by Zacks Equity Research
Kronos Worldwide (KRO) recorded year-over-year growth in earnings in second-quarter 2017 on the back of higher income from operations.
AK Steel (AKS) Wraps Up Precision Partners Acquisition
by Zacks Equity Research
AK Steel (AKS) has closed Precision Partners buyout, strengthening its portfolio of high-value products and processes.
Ride These 4 Momentum Stocks for Exciting Returns
by Zacks Equity Research
This screen will help you to get into momentum stocks that are storming ahead. Highlighted stocks include KRO, NTRI, BCO and AAOI.
Univar's (UNVR) Q2 Earnings Top Estimates, Revenues Miss
by Zacks Equity Research
Increasing margins contributed to Univar's (UNVR) second-quarter results.
Calgon Carbon (CCC) Q2 Earnings In Line, Sales Top Estimates
by Zacks Equity Research
Calgon Carbon's (CCC) second-quarter 2017 earnings benefited from improved demand of activated carbon products and services.
Albemarle (ALB) Q2 Earnings Top Estimates, Sales Fall Short
by Zacks Equity Research
Strong results from the Lithium and Advanced Materials unit helped Albemarle (ALB) top earnings expectations in Q2.
Andersons' (ANDE) Q2 Earnings Miss Estimates, Increase Y/Y
by Zacks Equity Research
Andersons (ANDE) Q2 earnings missed the Zacks Consensus Estimate, however improved year over year. In addition, revenues too registered a decline of 6.6%.
Westlake Chemical (WLK) Q2 Earnings Top, Sales Lag Estimates
by Zacks Equity Research
Westlake Chemical (WLK) delivered encouraging second-quarter 2017 results on the back of robust global demand of its key products and higher selling prices.
Air Products, TP JGC Coral France Ink Technology Supply Deal
by Zacks Equity Research
Air Products (APD) Inks a deal with TP JGC Coral France for a floating liquefied natural gas (FLNG) facility in Africa.
Goldcorp (GG) Announces Conclusion of Exeter Acquisition
by Zacks Equity Research
Goldcorp (GG) acquires all issued and outstanding shares of Exeter Resource Corporation through a court approved plan of arrangement.
Bet on Momentum with These ETFs & Stocks
by Sweta Killa
Dow Jones crossed the another milestone of 22,000 for the first time in yesterday???s trading session and the S&P 500 is less than 1% shy of its major threshold of 2,500.
CF Industries (CF) Q2 Earnings & Revenues Beat Estimates
by Zacks Equity Research
CF Industries' (CF) second-quarter 2017 earnings topped estimates on the back of higher utilization rates, record sales volume and cost efficiencies.
FMC Corporation (FMC) Jumps: Stock Rises 8.4%
by Zacks Equity Research
FMC Corporation (FMC) was a big mover last session, as the company saw its shares rise over 8% on the day amid huge volumes.
CVR Partners' Q2 Loss Lower than Expected, Sales Down Y/Y
by Zacks Equity Research
Cost reduction actions helped CVR Partners (UAN) post lower-than-expected loss in the second quarter.
Eastman Chemical (EMN) Q2 Earnings Top Estimates, Ups View
by Zacks Equity Research
Strength of high-margin products and cost actions helped Eastman Chemical (EMN) top earnings estimates in the second quarter.
Kronos (KRO) Scales New 52-Week High on Bright Prospects
by Zacks Equity Research
Shares of chemicals maker, Kronos (KRO), scaled a fresh 52-week high of $20.64 yesterday, before pulling back to eventually close the day at $20.47.
6 Reasons that Make Albemarle (ALB) a Solid Choice Now
by Zacks Equity Research
Strong fundamentals and compelling growth prospects make Albemarle an attractive choice for investment.
Eastman Chemical vs Albemarle: Which Stock Is a Better Pick?
by Zacks Equity Research
Which Zacks Rank #2 stock is better placed in terms of fundamentals - Eastman Chemical (EMN) or Albemarle (ALB)?
Allegheny (ATI), GE Aviation Form Meltless Titanium JV
by Zacks Equity Research
Allegheny (ATI) has formed a joint venture with GE Aviation for developing a new meltless titanium alloy powder manufacturing technology.
PolyOne to Sell DSS Unit to Arsenal Capital for $115 Million
by Zacks Equity Research
PolyOne (POL) is selling its Designed Structures and Solutions (DSS) business to Arsenal Capital Partners for $115 million.
AK Steel (AKS) to Buy Precision Partners for $360 Million
by Zacks Equity Research
AK Steel (AKS) has agreed to purchase Precision Partners Holding Company for $360 million in cash.
The Zacks Analyst Blog Highlights: Chemours, Kronos Worldwide, KMG Chemicals and BASF SE
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chemours, Kronos Worldwide, KMG Chemicals and BASF SE
U.S. Steel (X) Finalizes Sale of USSC to Bedrock Industries
by Zacks Equity Research
U.S. Steel (X) has finalized an agreement for the sale and transition of ownership of U.S. Steel Canada to Bedrock Industries.
5 Reasons to Add Eastman Chemical Stock to Your Portfolio
by Zacks Equity Research
Based on its compelling prospects, we believe Eastman Chemical (EMN) has plenty of upside potential.
4 Chemical Growth Stocks Worth Betting on Right Now
by Zacks Equity Research
As the chemical industry's upturn is expected to continue, it will be a prudent idea to zero in on these stocks with compelling growth prospects.